Arymo ER is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Egalet Us Inc.. The primary component is Morphine Sulfate.
| Product ID | 69344-111_a9e64fc1-683a-483e-8754-b759844174bb |
| NDC | 69344-111 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Arymo ER |
| Generic Name | Morphine Sulfate |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-02-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208603 |
| Labeler Name | Egalet US Inc. |
| Substance Name | MORPHINE SULFATE |
| Active Ingredient Strength | 15 mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208603 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-02-01 |
| Ingredient | Strength |
|---|---|
| MORPHINE SULFATE | 15 mg/1 |
| SPL SET ID: | e60552c9-06ce-4790-95e7-aadd4df12b2a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69344-211 | Arymo ER | Arymo ER |
| 69344-111 | Arymo ER | Arymo ER |
| 69344-311 | Arymo ER | Arymo ER |
| 0023-6011 | Kadian | morphine sulfate |
| 0023-6012 | Kadian | morphine sulfate |
| 0023-6013 | Kadian | morphine sulfate |
| 0023-6014 | Kadian | morphine sulfate |
| 0023-6015 | Kadian | morphine sulfate |
| 0023-6016 | Kadian | morphine sulfate |
| 0023-6017 | Kadian | morphine sulfate |
| 0023-6018 | Kadian | morphine sulfate |
| 0023-6019 | Kadian | morphine sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ARYMO 86270024 5191560 Live/Registered |
Egalet Ltd. 2014-05-02 |